COMPASS Pathways plc announces financial results and business highlights for the second quarter 2021 Post published:August 11, 2021 Post category:Press Release
MYND Life Sciences Announces DTC Eligibility Post published:August 11, 2021 Post category:Press Release
MindMed Appoints Dr. Robert Dworkin to Scientific Advisory Board Post published:August 10, 2021 Post category:Press Release
Tryp Therapeutics Partners with Calvert Labs to Conduct Exploratory Studies for Proprietary Psilocybin Formulations Post published:August 10, 2021 Post category:Press Release
MINDCURE Welcomes Dr. Ken Weingardt, Digital Therapy Visionary, as a Senior Clinical Technology Advisor to its Psychedelic Digital Therapeutics Team Post published:August 10, 2021 Post category:Press Release
Revive Therapeutics Provides Update on Psychedelics Clinical Product Pipeline Post published:August 10, 2021 Post category:Press Release
Clerkenwell Partners with Leading Preclinical CRO Transpharmation to Advance Psychedelic Clinical Trials in Europe Post published:August 9, 2021 Post category:Press Release
Levitee Labs Appoints NIH Physician-Scientist Dr. Fady Hannah-Shmouni as Chief Medical and Scientific Officer Post published:August 5, 2021 Post category:Press Release
PharmaDrug Forms Research Collaboration with Terasaki Institute for Novel Ocular Drug Formulation Program to Deliver DMT and Other Tryptamines to Treat Eye Disease Post published:August 5, 2021 Post category:Press Release
Silo Wellness Brings Marley One Mushrooms to the U.K. Market through Distribution Agreement with LocoSoco Limited Post published:August 5, 2021 Post category:Press Release